Clinical trial
Selenium Supplementation of Patients With Cirrhosis
NCT00271245 · Vanderbilt University, Other · Terminated
Key facts
| NCT number | NCT00271245 |
|---|---|
| Title | Selenium Supplementation of Patients With Cirrhosis |
| Official title | Selenium Supplementation of Patients With Cirrhosis |
| Lead sponsor | Vanderbilt University, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Liver Disease |
| Intervention type | Dietary Supplement |
| Interventions | 200 µg selenium as selenate, 400 µg selenium as selenate, 200 µg selenium as selenomethionine, Placebo |
| Enrollment | 99 |
| Start date | Feb 1, 2006 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Dec 30, 2005 |
| Last update posted | Mar 7, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: